NCT03325738View on ClinicalTrials.gov

Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

September 11, 2018

Conditions
Squamous Cell Cutaneous Carcinoma of the Skin
Trial Locations (1)

06189

PEYRADE Frédéric, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT03325738 - Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study | Biotech Hunter | Biotech Hunter